$AVGR - (IMPORTANT DD REMINDER FOR BULLS) “As we look ahead to 2021, we are excited about Avinger's current position. We enter the year with a well-funded balance sheet, with capital to cover our 2021 growth plans. In “JANUARY”, we expect to begin the full commercial launch of our Tigereye CTO device," said Soinski. "In order to drive further growth, we continue to advance our next generation Lightbox 3 imaging console, clinical studies in support of our products, and the development of new image-guided catheters for peripheral and coronary applications." Link to Full Article: finance.yahoo.com/news/avin...
  • 4
4 Likes